Aurinia Pharmaceuticals (AUPH)
(Real Time Quote from BATS)
$5.97 USD
+0.35 (6.23%)
Updated Jul 31, 2024 02:22 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Earnings News For AUPH
-
Aurinia: Q1 Earnings Snapshot
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
-
Aurinia: Q4 Earnings Snapshot
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
-
Aurinia: Q3 Earnings Snapshot
-
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
-
Aurinia: Q1 Earnings Snapshot
-
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Aurinia: Q4 Earnings Snapshot
-
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates
-
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Should You Buy?
-
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
-
Aurinia: Q3 Earnings Snapshot
-
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
-
Aurinia: Q2 Earnings Snapshot
-
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates